Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Vapotherm revenue
Vapotherm's revenue is $68.7 million.
What is Vapotherm's revenue?
- Vapotherm's revenue growth from 2017 to 2023 is 92.91%.
- Vapotherm has 276 employees, and the revenue per employee ratio is $248,800.
- Vapotherm's peak quarterly revenue was $40.9M in 2020(q4).
- Vapotherm peak revenue was $125.7M in 2020.
- Vapotherm annual revenue for 2022 was 66.8M, -41.04% growth from 2021.
- Vapotherm annual revenue for 2023 was 68.7M, 2.8% growth from 2022.
On this page
Zippi applies for you, and finds you a job.
Vapotherm historical revenue
Vapotherm's peak revenue was $125.7M in 2020. The peak quarterly revenue was $40.9M in 2020(q4).
Vapotherm's revenue increased from $35.6m in 2017 to $68.7M currently. That's a 92.91% change in annual revenue.
Vapotherm annual revenue
Vapotherm annual revenue over time
| Fiscal year / year | Vapotherm revenue |
|---|---|
| 2017 | $35.6M |
| 2018 | $42.4M |
| 2019 | $48.1M |
| 2020 | $125.7M |
| 2021 | $113.3M |
| 2022 | $66.8M |
| 2023 | $68.7M |
Rate Vapotherm's financial transparency
Vapotherm annual growth
Vapotherm saw the greatest revenue growth in 2020, when revenue increased by 161.38%.
Vapotherm had the lowest revenue growth in 2022, when revenue changed by -41.04%.
Vapotherm annual growth rate over time
| Year | Vapotherm growth |
|---|---|
| 2018 | 19%↑ |
| 2019 | 14%↑ |
| 2020 | 161%↑ |
| 2021 | -10%↓ |
| 2022 | -41%↓ |
| 2023 | 3%↑ |
Vapotherm quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Vapotherm quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | $11.7M |
| 2019 | $12.3M | $12.0M | $10.8M | $13.0M |
| 2020 | $19.1M | $35.2M | $30.6M | $40.9M |
| 2021 | $32.3M | $20.6M | $38.1M | $22.2M |
| 2022 | $21.6M | $13.0M | $13.5M | $18.7M |
| 2023 | $17.7M | $16.0M | $15.2M | $19.7M |
| 2024 | $19.1M | $16.9M | - | - |
Vapotherm jobs nearby
Do you work at Vapotherm?
Is Vapotherm transparent about its revenue structure?
Vapotherm financial information
| CEO | Joseph F. Army |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 276 |
| Date Founded | 1999 |
| Headquarters | Exeter, New Hampshire |
| Revenue | $68.7M |
| Net Income | -$113,259,000 |
| Gross Proft | $28.3M (2023) |
| Tax Rate | -0.0% |
| Total Assets | $96,195,000 |
| Ticker | VAPO |
Vapotherm jobs you might like
Vapotherm financing
Vapotherm received early financing of $5.3M on 2003-08-14.
| Series | Round size | Date |
|---|---|---|
| Series C | $5.3M | 08/2003 |
| Series D | $6.6M | 01/2006 |
| Series E | $11.3M | 11/2007 |
| Series F | $20.5M | 08/2008 |
| Series A | $29M | 04/2013 |
| Series B | $24M | 04/2014 |
| Series C | $20M | 07/2015 |
| Series C | $30M | 11/2015 |
| Series D | $45M | 05/2017 |
| Series D | $10M | 09/2018 |
| Post Ipo Debt | $52M | 10/2020 |
Vapotherm investors
| Investors | Security type |
|---|---|
| QuestMark Partners | Series C |
| Maryland Department of Business and Economic Development | Series C |
| QuestMark Partners | Series D |
| QuestMark Partners | Series E |
| Kaiser Permanente Ventures | Series E |
| Integral Capital Partners | Series F |
| QuestMark Partners | Series F |
| Kaiser Permanente Ventures | Series F |
| Cross Creek | Series F |
| GE Asset Management | Series F |
| Integral Capital Partners | Series A |
| QuestMark Partners | Series A |
| 3x5 Special Opportunity Fund | Series A |
| Kaiser Permanente Ventures | Series A |
| Morgenthaler Ventures | Series A |
| Cross Creek | Series A |
| GE Asset Management | Series A |
| Integral Capital Partners | Series B |
| QuestMark Partners | Series B |
| 3x5 Special Opportunity Fund | Series B |
| Kaiser Permanente Ventures | Series B |
| Adage Capital Management | Series B |
| Morgenthaler Ventures | Series B |
| Cross Creek | Series B |
| Gilde Healthcare | Series B |
| QuestMark Partners | Series C |
| SightLine Partners | Series C |
| Kaiser Permanente Ventures | Series C |
| Adage Capital Management | Series C |
| Morgenthaler Ventures | Series C |
| Crestline | Series C |
| Cross Creek | Series C |
| Gilde Healthcare | Series C |
| QuestMark Partners | Series C |
| Kaiser Permanente Ventures | Series C |
| Adage Capital Management | Series C |
| Perceptive Advisors | Series C |
| Arnerich Massena & Associates | Series C |
| Morgenthaler Ventures | Series C |
| Redmile Group | Series D |
| SightLine Partners | Series D |
| Perceptive Advisors | Series D |
| Morgenthaler Ventures | Series D |
| Gilde Healthcare | Series D |
| Redmile Group | Series D |
| SightLine Partners | Series D |
| Perceptive Advisors | Series D |
| Morgenthaler Ventures | Series D |
| Gilde Healthcare | Series D |
| CIBC Innovation Banking | Post Ipo Debt |
Vapotherm competitors
Vapotherm's top competitor, Stryker, earned an annual revenue of $22.6B.
Vapotherm's smallest competitor is PolyPid with revenue of $1.6M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Abiomed | $99,022 | $1.0B | 1,536 | - |
| I-Flow Corporation | $69,708 | $1.6B | 1,100 | - |
| Arthrocare | $64,919 | $378.0M | 1,000 | - |
| Stryker | $69,470 | $22.6B | 43,000 | 2,282 |
| Cardiovascular Systems | $64,526 | $236.2M | 780 | - |
| PolyPid | $64,868 | $1.6M | 77 | - |
| Hillrom | $59,479 | $3.0B | 10,000 | 136 |
| NuVasive | $75,654 | $1.2B | 2,800 | - |
| Joerns Healthcare LLC | $52,213 | $360.0M | 3,000 | 10 |
| IDEXX | $59,931 | $3.9B | 9,300 | 287 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Vapotherm highest paying jobs
Zippia gives an in-depth look into the details of Vapotherm, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Vapotherm. The employee data is based on information from people who have self-reported their past or current employments at Vapotherm. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Vapotherm. The data presented on this page does not represent the view of Vapotherm and its employees or that of Zippia.
Vapotherm may also be known as or be related to VAPOTHERM INC, Vapotherm, Vapotherm Inc and Vapotherm, Inc.